SEC Form 4/A · accession 0001140361-18-020306
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Daniel K Spiegelman
Officer — EVP, Chief Financial Officer
Period of report
Mar 22, 2018
Accepted (ET)
Apr 27, 2018 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 22, 2018 | F | 3,598 | $81.36 | D | 73,587 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed solely to correct an administrative error in the original filing regarding the number of shares reported as forfeited.